Plain-English translation of NCT07135570 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This trial is testing whether artificial intelligence-assisted eye screening can help find common eye diseases early in communities with limited access to eye care. Researchers will use AI technology to help screen for conditions like glaucoma, cataracts, diabetic retinopathy, and age-related macular degeneration in coastal Bangladesh. The goal is to identify people with eye disease so they can get treatment before they lose their vision.
Many people in coastal Bangladesh have no access to eye exams and go blind from treatable diseases. This trial tests whether using AI technology and local volunteers can make screening faster, easier, and more available in remote areas where there are few eye doctors.
You likely qualify if…
You likely don't qualify if…
You would visit a local screening site where trained volunteers would use AI technology to check your eyes for signs of disease. The screening is non-invasive and uses special cameras and software to look for problems. If the screening finds a possible eye disease, you would be referred to an eye hospital for further evaluation and treatment.
AI-generated summary from trial data · Jun 12, 2026 · Not medical advice
Bangladesh
Collaborators
Bangladesh Disaster Preparedness Centre
Enrollment target
~20,000 participants
Started
January 2025
Primary completion
December 2025
This trial's estimated completion date has passed — the record may not be fully up to date.
Age range
35 Years and older
Last updated on clinicaltrials.gov in August 2025.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Mohammad Saidur Rahman, PhD
Data Yakka, Inc.
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.